Periodontal Therapy on the Gut Microbiome of Inflammatory Bowel Disease
Effect of Intensive or Conventional Periodontal Therapy on the Gut Microbiome and Systemic Inflammation of Patients With Inflammatory Bowel Disease: a Single-blinded Randomized Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Periodontitis and inflammatory bowel disease have been associated by meta-epidemiologic evidence, although their mechanistic connection needs to be further explored. Oral-gut axis is implicated in the pathogenesis of several chronic inflammatory conditions, but to date no studies have evaluated the impact of periodontal treatment on gut ecology. Thus, the present randomised clinical trial is aimed at investigating the effect of intensive or conventional periodontal therapy on the gut microbiome and parameters of systemic inflammation of patients diagnosed with inflammatory bowel disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 10, 2021
CompletedStudy Start
First participant enrolled
May 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2023
CompletedNovember 2, 2022
October 1, 2022
2 years
February 4, 2021
October 31, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in microbiome alpha diversity measured from stool samples at 3 months
Taxonomic and functional variation of gut bacteria after treatment
Baseline and 90 days
Secondary Outcomes (5)
Changes in microbiome alpha diversity measured from saliva samples at 3 months
Baseline and 90 days
Change of the inflammatory markers levels in plasma
Baseline and 90 days
Changes in mean clinical attachment level (CAL) at 3 months
Baseline and 90 days
Changes in periodontal pocket depth (PPD) at 3 months
Baseline and 90 days
Changes in full mouth bleeding score (FMBS) at 3 months
Baseline and 90 days
Study Arms (2)
Intensive periodontal treatment
EXPERIMENTALAdjunctive full-mouth intensive removal of subgingival dental plaque biofilms with the use of scaling and root planing after the administration of local anesthesia.
Community-based periodontal care
ACTIVE COMPARATORStandard cycle of supragingival mechanical scaling and polishing.
Interventions
Subgingival instrumentation with ultrasonic devices and curettes of all periodontal pockets completed within 48 hours
Eligibility Criteria
You may qualify if:
- clinical and instrumental diagnosis of ulcerative colitis or Crohn's disease
- periodontitis Stage III or IV
- BMI between 20 and 29 kg/m2
- free diet
- presence of at least 20 teeth
You may not qualify if:
- Systemic diseases (including diabetes, thyroid, liver, or kidney diseases)
- dietary allergies
- use of antibiotics or probiotics during the previous 30 days
- pregnancy or breast feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CIR Dental School
Turin, 10126, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2021
First Posted
March 10, 2021
Study Start
May 2, 2021
Primary Completion
May 15, 2023
Study Completion
May 15, 2023
Last Updated
November 2, 2022
Record last verified: 2022-10